Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Sotrovimab

Product Specifications

Target

SARS-CoV

Related Pathways

Microbiology/Virology

Purity

0.987

Bioactivity

Sotrovimab (VIR 7831) is a monoclonal antibody against the SARS-CoV-2 virus that causes COVID-19. It has antiviral activity, induces serum neutralization of BQ.1 and antibody-dependent cytotoxicity, and may be used to study viral infections.

Shipping Conditions

Cool pack

Storage Temperature

-20°C

Product Datasheet

https://www.targetmol.com/attachment/DataSheet/64416316521447429/T76845

CAS Number

2423014-07-5

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

4,4'-Oxybis[p-(phenylsulfonylaniline)] Hydrochloride
TRC-O870561-50MG 50 mg

4,4'-Oxybis[p-(phenylsulfonylaniline)] Hydrochloride

Ask
View Details
Identification of human specific ß-Actin
FR799 100 Reactions

Identification of human specific ß-Actin

Ask
View Details
Recombinant Coxiella burnetii 7-cyano-7-deazaguanine synthase (queC)
MBS1481804-01 0.02 mg (E-Coli)

Recombinant Coxiella burnetii 7-cyano-7-deazaguanine synthase (queC)

Ask
View Details
Recombinant Coxiella burnetii 7-cyano-7-deazaguanine synthase (queC)
MBS1481804-02 0.1 mg (E-Coli)

Recombinant Coxiella burnetii 7-cyano-7-deazaguanine synthase (queC)

Ask
View Details
Recombinant Coxiella burnetii 7-cyano-7-deazaguanine synthase (queC)
MBS1481804-03 0.02 mg (Yeast)

Recombinant Coxiella burnetii 7-cyano-7-deazaguanine synthase (queC)

Ask
View Details
Recombinant Coxiella burnetii 7-cyano-7-deazaguanine synthase (queC)
MBS1481804-04 0.1 mg (Yeast)

Recombinant Coxiella burnetii 7-cyano-7-deazaguanine synthase (queC)

Ask
View Details